Data / Form D filings / i2O Therapeutics, Inc.
i2O Therapeutics, Inc.: Form D filings
i2O Therapeutics, Inc., a biotechnology company in Cambridge, MA, filed 6 Form D notices with the SEC between 2019 and 2023. The latest, on October 18, 2023, reports $3.5 million sold of a $4 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 610 Main Street, Cambridge, MA, 02139
- Phone
- (408) 476-1904
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1782226
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 18, 2023 | New notice | $3,987,042 | $3,500,000 | $487,042 | 7 | Sep 18, 2023 | sec.gov |
| Oct 11, 2022 | New notice | $42,032,225 | $33,539,921 | $8,492,304 | 17 | Jul 18, 2022 | sec.gov |
| Jan 24, 2022 | New notice | $3,000,000 | $2,300,000 | $700,000 | 7 | Oct 1, 2021 | sec.gov |
| Dec 1, 2020 | New notice | $600,000 | $600,000 | 2 | Nov 16, 2020 | sec.gov | |
| Mar 23, 2020 | New notice | $3,200,000 | $3,200,000 | 2 | Mar 13, 2020 | sec.gov | |
| Jul 11, 2019 | New notice | $4,000,000 | $800,000 | $3,200,000 | 2 | Jun 27, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Gagliardi | Director | |
| Kurt Graves | Executive Officer, Director | |
| Anthony Aiudi | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Oct 16, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what i2O Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.